Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 19 de 19
Filtrar
1.
Artigo em Inglês | MEDLINE | ID: mdl-33681915

RESUMO

INTRODUCTION: Leprosy recurrence is the reappearance of the disease after treatment with current schemes and discharged for cure and may have variable incubation periods. METHODS: This is a descriptive observational study of leprosy recurrence in Espírito Santo diagnosed between January 2018 and January 2020. RESULTS: One hundred and ninety-two cases were available, of which 30 were diagnosed with leprosy recurrence. CONCLUSIONS: In 25 cases, the incubation period was 5-15 years after the first treatment, favoring bacillary persistence. In the remaining 5 cases, the disease had recurred after 15 years, pointing to reinfection as none of them exhibited drug resistance.


Assuntos
Hanseníase , Brasil , Resistência a Medicamentos , Humanos , Hanseníase/tratamento farmacológico , Recidiva , Centros de Atenção Terciária
2.
Rev. Soc. Bras. Med. Trop ; 54: e0375-2020, 2021. tab
Artigo em Inglês | LILACS | ID: biblio-1155553

RESUMO

Abstract INTRODUCTION: Leprosy recurrence is the reappearance of the disease after treatment with current schemes and discharged for cure and may have variable incubation periods. METHODS: This is a descriptive observational study of leprosy recurrence in Espírito Santo diagnosed between January 2018 and January 2020. RESULTS: One hundred and ninety-two cases were available, of which 30 were diagnosed with leprosy recurrence. CONCLUSIONS: In 25 cases, the incubation period was 5-15 years after the first treatment, favoring bacillary persistence. In the remaining 5 cases, the disease had recurred after 15 years, pointing to reinfection as none of them exhibited drug resistance.


Assuntos
Humanos , Hanseníase/tratamento farmacológico , Recidiva , Brasil , Resistência a Medicamentos , Centros de Atenção Terciária
3.
An Bras Dermatol ; 94(2): 236-238, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31090835

RESUMO

Leprosy is a chronic neglected and stigmatizing disease. Due to involvement of the peripheral nerves, it can result in physical disabilities, deformities, and emotional damage if not diagnosed and treated promptly. This is the case of a young patient with testicular pain and swelling and no improvement after a specific therapeutic scheme for tuberculosis. Clinical and laboratory reevaluation revealed hypoesthetic skin patches associated with post-burn crusted ulcers on the left arm, thickening of ulnar nerves, atrophy of interosseous muscles of the hands, positive skin smear microscopy, and testicular histopathology with numerous bacilli forming globi. These findings indicated lepromatous leprosy with type II reaction.


Assuntos
Diagnóstico Tardio , Hanseníase Virchowiana/diagnóstico , Doenças Testiculares/tratamento farmacológico , Tuberculose dos Genitais Masculinos/tratamento farmacológico , Úlcera/diagnóstico , Adulto , Braço , Humanos , Hanseníase Virchowiana/complicações , Masculino , Orquite/complicações , Orquite/diagnóstico , Doenças Testiculares/patologia , Tempo para o Tratamento , Úlcera/complicações
4.
An. bras. dermatol ; 94(2): 236-238, Mar.-Apr. 2019. graf
Artigo em Inglês | LILACS | ID: biblio-1001142

RESUMO

Abstract Leprosy is a chronic neglected and stigmatizing disease. Due to involvement of the peripheral nerves, it can result in physical disabilities, deformities, and emotional damage if not diagnosed and treated promptly. This is the case of a young patient with testicular pain and swelling and no improvement after a specific therapeutic scheme for tuberculosis. Clinical and laboratory reevaluation revealed hypoesthetic skin patches associated with post-burn crusted ulcers on the left arm, thickening of ulnar nerves, atrophy of interosseous muscles of the hands, positive skin smear microscopy, and testicular histopathology with numerous bacilli forming globi. These findings indicated lepromatous leprosy with type II reaction.


Assuntos
Humanos , Masculino , Adulto , Doenças Testiculares/tratamento farmacológico , Tuberculose dos Genitais Masculinos/tratamento farmacológico , Úlcera/diagnóstico , Hanseníase Virchowiana/diagnóstico , Diagnóstico Tardio , Orquite/complicações , Orquite/diagnóstico , Braço , Doenças Testiculares/patologia , Úlcera/complicações , Hanseníase Virchowiana/complicações
5.
An. bras. dermatol ; 93(6): 824-828, Nov.-Dec. 2018. graf
Artigo em Inglês | LILACS | ID: biblio-973623

RESUMO

Abstract: Background: Leprosy is a chronic infectious disease that is endemic in Brazil and little studied in patients over 60 years old. Objective: The aim of this study was the epidemiological and clinical description of cases of leprosy in individuals older than 60 years, notified in the State of Espírito Santo - Brazil. Methods: It was an observational, descriptive and retrospective study of leprosy patients notified between 2001 and 2011. Results: Out of 16,025 notifications, 2,510 (15.6%) were of patients over 60 years of age; the distribution among the period was egalitarian except in the last 2 years, when there was a mild reduction of cases; the average was 70 years of age (±7 years); 46% were women, being 62% of those paucibacillary cases; 1,145 (50.5%) were dark-skined people in particular among paucibacillary cases; 1,638 (72.9%) were illiterates or poorly instructed n particular among multibacillary cases (P=0.022); 59.9% patients were clinically multibacillary cases and 37.4% had positive bacilloscopy; 37.9% patients had clinical alterations on peripheral nerves, 36.7% of all the multibacillary cases were classified as grade I and 15.3% as grade in assessment of disability. Study limitations: This was a retrospective study, which used secondary data generated by physicians and notified by other professionals, whar could have enabled possible errors on original data. Conclusions: Leprosy in this age group suggests a long incubation period with reactivation of latent focus or late infection. Men were more affected, as well as the afro descendent race was statistically significant in the paucibacillary cases (P=0.000) and illiterate/poor education in multibacillary cases (P=0.022). Nearly 40% of patients had positive bacilloscopy and grade I/II disability, demonstrating a late diagnosis.


Assuntos
Humanos , Masculino , Feminino , Pessoa de Meia-Idade , Idoso , Idoso de 80 Anos ou mais , Hanseníase Multibacilar/epidemiologia , Hanseníase Paucibacilar/epidemiologia , Índice de Gravidade de Doença , Brasil/epidemiologia , Estudos Retrospectivos , Distribuição por Idade , Notificação de Doenças
6.
An Bras Dermatol ; 93(6): 824-828, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-30484526

RESUMO

BACKGROUND: Leprosy is a chronic infectious disease that is endemic in Brazil and little studied in patients over 60 years old. OBJECTIVE: The aim of this study was the epidemiological and clinical description of cases of leprosy in individuals older than 60 years, notified in the State of Espírito Santo - Brazil. METHODS: It was an observational, descriptive and retrospective study of leprosy patients notified between 2001 and 2011. RESULTS: Out of 16,025 notifications, 2,510 (15.6%) were of patients over 60 years of age; the distribution among the period was egalitarian except in the last 2 years, when there was a mild reduction of cases; the average was 70 years of age (±7 years); 46% were women, being 62% of those paucibacillary cases; 1,145 (50.5%) were dark-skined people in particular among paucibacillary cases; 1,638 (72.9%) were illiterates or poorly instructed n particular among multibacillary cases (P=0.022); 59.9% patients were clinically multibacillary cases and 37.4% had positive bacilloscopy; 37.9% patients had clinical alterations on peripheral nerves, 36.7% of all the multibacillary cases were classified as grade I and 15.3% as grade in assessment of disability. STUDY LIMITATIONS: This was a retrospective study, which used secondary data generated by physicians and notified by other professionals, whar could have enabled possible errors on original data. CONCLUSIONS: Leprosy in this age group suggests a long incubation period with reactivation of latent focus or late infection. Men were more affected, as well as the afro descendent race was statistically significant in the paucibacillary cases (P=0.000) and illiterate/poor education in multibacillary cases (P=0.022). Nearly 40% of patients had positive bacilloscopy and grade I/II disability, demonstrating a late diagnosis.


Assuntos
Hanseníase Multibacilar/epidemiologia , Hanseníase Paucibacilar/epidemiologia , Distribuição por Idade , Idoso , Idoso de 80 Anos ou mais , Brasil/epidemiologia , Notificação de Doenças , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Índice de Gravidade de Doença
7.
An. bras. dermatol ; 91(5,supl.1): 60-63, Sept.-Oct. 2016. tab, graf
Artigo em Inglês | LILACS | ID: biblio-837947

RESUMO

Abstract Lucio’s phenomenon is an uncommon reaction characterized by severe necrotizing cutaneous lesions that occurs in patients with Lucio’s leprosy and lepromatous leprosy. It is considered by some authors as a variant of type 2 or 3 reaction. Death can occur because of blood dyscrasia or sepsis. Precipitating factors include infections, drugs and pregnancy. We report a 31-year-old female patient exhibiting both clinical and histopathological features of lepromatous leprosy and Lucio’s phenomenon presenting favorable response to treatment. We complement our report with a literature review of the Brazilian cases of Lucio’s phenomenon published in Portuguese and English.


Assuntos
Humanos , Feminino , Adulto , Úlcera Cutânea/patologia , Hanseníase Virchowiana/patologia , Pele/patologia , Úlcera Cutânea/tratamento farmacológico , Biópsia , Índice de Gravidade de Doença , Brasil , Hanseníase Virchowiana/tratamento farmacológico , Resultado do Tratamento , Necrose
8.
An Bras Dermatol ; 91(2): 196-203, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-27192519

RESUMO

Leprosy is a chronic infectious disease caused by Mycobacterium leprae, representing a public health issue in some countries. Though more prevalent in adults, the detection of new cases in children under 15 years of age reveals an active circulation of bacillus, continued transmission and lack of disease control by the health system, as well as aiding in the monitoring of the endemic. Among patients under 15 years of age, the most affected age group is children between 10 and 14 years of age, although cases of patients of younger than 1 year of age have also been reported. Household contacts are the primary source of infection, given that caretakers, such as babysitters and others, must be considered in this scenario. Paucibacillary forms of the disease prevailed, especially borderline-tuberculoid leprosy, with a single lesion in exposed areas of the body representing the main clinical manifestation. Reactional states: Lepra reactions are rare, although some authors have reported high frequencies of this phenomenon, the most frequent of which is Type 1 Lepra Reaction. Peripheral nerve involvement has been described at alarming rates in some studies, which increases the chance of deformities, a serious problem, especially if one considers the age of these patients. The protective effect of BCG vaccination was found in some studies, but no consensus has been reached among different authors. Children must receive the same multidrug therapy regimen and the doses should, ideally, be calculated based on the child´s weight. Adverse reactions to this therapy are rare within this age group. This article aims to review epidemiological, clinical, and therapeutic aspects of leprosy in patients under 15 years of age.


Assuntos
Hanseníase Multibacilar/tratamento farmacológico , Hanseníase Multibacilar/patologia , Hanseníase Paucibacilar/tratamento farmacológico , Hanseníase Paucibacilar/patologia , Adolescente , Fatores Etários , Vacina BCG/uso terapêutico , Brasil/epidemiologia , Criança , Feminino , Humanos , Hansenostáticos/uso terapêutico , Hanseníase Multibacilar/epidemiologia , Hanseníase Paucibacilar/epidemiologia , Masculino , Fatores de Risco
9.
An. bras. dermatol ; 91(2): 196-203, Mar.-Apr. 2016. tab, graf
Artigo em Inglês | LILACS | ID: lil-781355

RESUMO

Abstract Leprosy is a chronic infectious disease caused by Mycobacterium leprae, representing a public health issue in some countries. Though more prevalent in adults, the detection of new cases in children under 15 years of age reveals an active circulation of bacillus, continued transmission and lack of disease control by the health system, as well as aiding in the monitoring of the endemic. Among patients under 15 years of age, the most affected age group is children between 10 and 14 years of age, although cases of patients of younger than 1 year of age have also been reported. Household contacts are the primary source of infection, given that caretakers, such as babysitters and others, must be considered in this scenario. Paucibacillary forms of the disease prevailed, especially borderline-tuberculoid leprosy, with a single lesion in exposed areas of the body representing the main clinical manifestation. Reactional states: Lepra reactions are rare, although some authors have reported high frequencies of this phenomenon, the most frequent of which is Type 1 Lepra Reaction. Peripheral nerve involvement has been described at alarming rates in some studies, which increases the chance of deformities, a serious problem, especially if one considers the age of these patients. The protective effect of BCG vaccination was found in some studies, but no consensus has been reached among different authors. Children must receive the same multidrug therapy regimen and the doses should, ideally, be calculated based on the child´s weight. Adverse reactions to this therapy are rare within this age group. This article aims to review epidemiological, clinical, and therapeutic aspects of leprosy in patients under 15 years of age.


Assuntos
Humanos , Masculino , Feminino , Criança , Adolescente , Hanseníase Multibacilar/patologia , Hanseníase Multibacilar/tratamento farmacológico , Hanseníase Paucibacilar/patologia , Hanseníase Paucibacilar/tratamento farmacológico , Brasil/epidemiologia , Vacina BCG/uso terapêutico , Fatores de Risco , Fatores Etários , Hanseníase Multibacilar/epidemiologia , Hanseníase Paucibacilar/epidemiologia , Hansenostáticos/uso terapêutico
10.
An Bras Dermatol ; 91(5 suppl 1): 60-63, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-28300896

RESUMO

Lucio's phenomenon is an uncommon reaction characterized by severe necrotizing cutaneous lesions that occurs in patients with Lucio's leprosy and lepromatous leprosy. It is considered by some authors as a variant of type 2 or 3 reaction. Death can occur because of blood dyscrasia or sepsis. Precipitating factors include infections, drugs and pregnancy. We report a 31-year-old female patient exhibiting both clinical and histopathological features of lepromatous leprosy and Lucio's phenomenon presenting favorable response to treatment. We complement our report with a literature review of the Brazilian cases of Lucio's phenomenon published in Portuguese and English.


Assuntos
Hanseníase Virchowiana/patologia , Úlcera Cutânea/patologia , Adulto , Biópsia , Brasil , Feminino , Humanos , Hanseníase Virchowiana/tratamento farmacológico , Necrose , Índice de Gravidade de Doença , Pele/patologia , Úlcera Cutânea/tratamento farmacológico , Resultado do Tratamento
11.
Mycoses ; 57(9): 565-71, 2014 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-24724729

RESUMO

Pityriasis versicolor is a frequent mycosis and the use of systemic corticotherapy is one of its predisposing factors. This is an observational, cross-sectional, analytical and comparative study, conducted from January 2012 to January 2013 in the following outpatient clinics: Dermatology Service, Cassiano Antonio Moraes Hospital (HUCAM), Vitória, ES, Brazil; Nephrology Service, HUCAM; and Leprosy Department, Maruípe Health Unit, Vitória, ES, Brazil. Patients, undergoing long-term systemic corticotherapy (or not), were assessed with respect to the presence of pityriasis versicolor. If there was mycosis, a direct mycological examination would be carried out. The spss 17.0 software was used for the statistical analysis. From the total of 100 patients, nine had pityriasis versicolor, being eight from the corticotherapy group and one from the group with no use of corticosteroids. Regarding the patients with mycosis, the prevalent age ranged from 20 to 39 years, with six patients; six were women; seven mixed race; eight were undergoing long-term systemic corticotherapy; seven were taking low-dose systemic corticosteroids; four had leucocytosis; five had normal total cholesterol and triglycerides; and four had normal glycaemia. There was increased frequency of pityriasis versicolor in the group undergoing systemic corticotherapy with statistical significance, corroborating the only study on the topic (1962).


Assuntos
Corticosteroides/efeitos adversos , Tinha Versicolor/induzido quimicamente , Corticosteroides/uso terapêutico , Adulto , Idoso , Brasil , Estudos Transversais , Feminino , Humanos , Incidência , Masculino , Pessoa de Meia-Idade , Adulto Jovem
12.
J Clin Microbiol ; 50(6): 1912-7, 2012 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-22495562

RESUMO

Skin biopsy samples from 145 relapse leprosy cases and from five different regions in Brazil were submitted for sequence analysis of part of the genes associated with Mycobacterium leprae drug resistance. Single nucleotide polymorphisms (SNPs) in these genes were observed in M. leprae from 4 out of 92 cases with positive amplification (4.3%) and included a case with a mutation in rpoB only, another sample with SNPs in both folP1 and rpoB, and two cases showing mutations in folP1, rpoB, and gyrA, suggesting the existence of multidrug resistance (MDR). The nature of the mutations was as reported in earlier studies, being CCC to CGC in codon 55 in folP (Pro to Arg), while in the case of rpoB, all mutations occurred at codon 531, with two being a transition of TCG to ATG (Ser to Met), one TCG to TTC (Ser to Phe), and one TCG to TTG (Ser to Leu). The two cases with mutations in gyrA changed from GCA to GTA (Ala to Val) in codon 91. The median time from cure to relapse diagnosis was 9.45 years but was significantly shorter in patients with mutations (3.26 years; P = 0.0038). More than 70% of the relapses were multibacillary, including three of the mutation-carrying cases; one MDR relapse patient was paucibacillary.


Assuntos
Antibacterianos/farmacologia , Farmacorresistência Bacteriana , Hanseníase/epidemiologia , Hanseníase/microbiologia , Mycobacterium leprae/efeitos dos fármacos , Mycobacterium leprae/isolamento & purificação , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Biópsia , Brasil/epidemiologia , DNA Bacteriano/química , DNA Bacteriano/genética , Feminino , Genes Bacterianos , Humanos , Masculino , Pessoa de Meia-Idade , Mutação de Sentido Incorreto , Mutação Puntual , Polimorfismo de Nucleotídeo Único , Prevalência , Estudos Prospectivos , Recidiva , Análise de Sequência de DNA , Pele/microbiologia , Adulto Jovem
13.
Cad Saude Publica ; 28(1): 31-8, 2012 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-22267063

RESUMO

Leprosy may present acute/subacute inflammatory processes (leprosy reactions). The study characterized the reactional states of patients at health clinics in Vitória, Espírito Santo State, Brazil, and associated them with sociodemographic factors and clinical/nutritional variables. between January and December 2009, longitudinal follow-up of patients with leprosy continued until leprosy reactions occurred or patients completed 6 months of multidrug therapy. Of the 151 patients participating, 78 (51.7%) were females, 48 (31.8%) had 5 to 8 years schooling, 93 (61.6%) worked and earned from 1 to 3 minimum wages, and 55 (36.4 %) had leprosy reactions, but with no statistical association to socioeconomic characteristics or nutritional status. However, absence of reaction was more common in the low-weight group, suggesting a trend in this group to protection from the reaction (p = 0.0906). The study found no association between nutritional status and leprosy reaction.


Assuntos
Hanseníase/epidemiologia , Estado Nutricional/fisiologia , Atenção Primária à Saúde/estatística & dados numéricos , Adolescente , Adulto , Distribuição por Idade , Idoso , Índice de Massa Corporal , Tamanho Corporal , Brasil/epidemiologia , Criança , Feminino , Seguimentos , Humanos , Hanseníase/diagnóstico , Masculino , Pessoa de Meia-Idade , Distribuição por Sexo , Fatores Socioeconômicos , Adulto Jovem
14.
Cad. saúde pública ; 28(1): 31-38, jan. 2012.
Artigo em Inglês | LILACS | ID: lil-610732

RESUMO

Leprosy may present acute/subacute inflammatory processes (leprosy reactions). The study characterized the reactional states of patients at health clinics in Vitória, Espírito Santo State, Brazil, and associated them with sociodemographic factors and clinical/nutritional variables. between January and December 2009, longitudinal follow-up of patients with leprosy continued until leprosy reactions occurred or patients completed 6 months of multidrug therapy. Of the 151 patients participating, 78 (51.7 percent) were females, 48 (31.8 percent) had 5 to 8 years schooling, 93 (61.6 percent) worked and earned from 1 to 3 minimum wages, and 55 (36.4 percent) had leprosy reactions, but with no statistical association to socioeconomic characteristics or nutritional status. However, absence of reaction was more common in the low-weight group, suggesting a trend in this group to protection from the reaction (p = 0.0906). The study found no association between nutritional status and leprosy reaction.


A hanseníase pode apresentar processos inflamatórios agudos/subagudos (reações hansênicas). Os objetivos foram caracterizar os estados reacionais de pacientes de Unidades de Saúde da Grande Vitória (Espírito Santo, Brasil) e associá-los aos fatores sociodemográficos e a variáveis clínicas/nutricionais. Estudo longitudinal, de monitoramento de portadores de hanseníase acompanhados até o aparecimento da reação hansênica ou até 6 meses iniciais da poliquimioterapia, de janeiro a dezembro de 2009. Participaram 151 pacientes, sendo 78 (51,7 por cento) femininos; 48 (31,8 por cento) estudaram de cinco a oito anos; 93 (61,6 por cento) trabalhavam e ganhavam de um a três salários mínimos; 55 (36,4 por cento) apresentaram reação hansênica, sem associação estatística às características socioeconômicas nem ao estado nutricional. Porém, a ausência de reação foi maior no grupo baixo peso, sugerindo neste grupo tendência na proteção da reação (p = 0,0906). No estudo não houve associação do estado nutricional com a reação hansênica.


Assuntos
Adolescente , Adulto , Idoso , Criança , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Adulto Jovem , Hanseníase/epidemiologia , Estado Nutricional/fisiologia , Atenção Primária à Saúde/estatística & dados numéricos , Distribuição por Idade , Índice de Massa Corporal , Tamanho Corporal , Brasil/epidemiologia , Seguimentos , Hanseníase/diagnóstico , Distribuição por Sexo , Fatores Socioeconômicos
15.
Rev Soc Bras Med Trop ; 43(6): 695-9, 2010.
Artigo em Português | MEDLINE | ID: mdl-21181026

RESUMO

INTRODUCTION: In 1997, after obtaining a combined multi-state double-blind randomly controlled clinical trial study from nine Indian centers involved in the treatment of Hansen's Disease, the Ministry of Health adapted the single dose ROM Therapy approach in those cases involving the treatment of a single skin lesion, paucibacillary leprosy without evidence of peripheral nerve trunk involvement and indication of negative baciloscope, in the Referral Centers in Brazil. The study aimed to evaluate the effectiveness of the single dose ROM Therapy approach in those patients who were treated from the period of 1997 to 1999 in the Ambulatory Dermatologic Unit in the Hospital in Vitória, ES. METHODS: Fifty-four patients with tuberculoid and indeterminate leprosy were selected and treated with the single dose ROM Therapy approach. These patients were contacted from March 2006 up and until October 2006 for further clinical reevaluation. RESULTS: From the studies conducted, the following results were found to exist: 29 patients (85,2%; 95%CI: 70-100,4) were cured, 5 patients (14,7%; 95%CI: 7,4-22,0) relapsed, and 20 patients didn't return; however, there are no additional records of any notification of other treatment(s) in the State Department of Health's informational data banks. CONCLUSIONS: The study demonstrated a rate of cure of 90.8% and a rate of relapse of 9.2% after a period of seven to nine years using the single dose ROM Therapy approach. Additionally, this alternative treatment further demonstrated a better effectiveness for a single skin lesion smaller than four centimeters and with an appearance in less than five years.


Assuntos
Hansenostáticos/administração & dosagem , Hanseníase/tratamento farmacológico , Minociclina/administração & dosagem , Ofloxacino/administração & dosagem , Rifampina/administração & dosagem , Adolescente , Adulto , Método Duplo-Cego , Esquema de Medicação , Quimioterapia Combinada/métodos , Feminino , Humanos , Hanseníase/patologia , Hanseníase Tuberculoide/tratamento farmacológico , Hanseníase Tuberculoide/patologia , Estudos Longitudinais , Masculino , Pessoa de Meia-Idade , Recidiva , Fatores de Tempo , Resultado do Tratamento , Adulto Jovem
16.
Rev. Soc. Bras. Med. Trop ; 43(6): 695-699, Nov.-Dec. 2010. tab
Artigo em Português | LILACS | ID: lil-569434

RESUMO

INTRODUÇÃO: Em 1997, após a realização de estudo multicêntrico, duplo cego e randomizado, em nove centros de tratamento de hanseníase na Índia, o Ministério da Saúde adotou o esquema alternativo dose única ROM para casos de lesão única, paucibacilar, sem nervo periférico afetado, índice baciloscópico negativo, em Centros de Referência da doença no Brasil. O estudo se propôs a avaliar a efetividade do esquema ROM em pacientes tratados no período de 1997 a 1999 no Serviço de Dermatologia da Santa Casa de Vitória. MÉTODOS: Foram selecionados e tratados com o esquema ROM, 54 pacientes das formas indeterminada e tuberculóide. Estes pacientes foram convocados de março a outubro de 2006 para reavaliação clínica. RESULTADOS: Vinte e nove pacientes avaliados (85,2 por cento; IC95 por cento: 70-100,4) estavam curados, cinco (14,7 por cento; IC95 por cento: 7,4-22,0) recidivaram e 20 pacientes não retornaram; porém, não havia outra notificação de reingresso ao tratamento no banco de dados da Secretaria Estadual de Saúde. CONCLUSÕES: O estudo evidenciou taxa de cura de 90,8 por cento e taxa bruta de recidiva de 9,2 por cento, após período de sete a nove anos da dose ROM. O tratamento alternativo ROM demonstrou melhor efetividade para lesão única menor que quatro centímetros e aparecimento há menos de cinco anos.


INTRODUCTION: In 1997, after obtaining a combined multi-state double-blind randomly controlled clinical trial study from nine Indian centers involved in the treatment of Hansen's Disease, the Ministry of Health adapted the single dose ROM Therapy approach in those cases involving the treatment of a single skin lesion, paucibacillary leprosy without evidence of peripheral nerve trunk involvement and indication of negative baciloscope, in the Referral Centers in Brazil. The study aimed to evaluate the effectiveness of the single dose ROM Therapy approach in those patients who were treated from the period of 1997 to 1999 in the Ambulatory Dermatologic Unit in the Hospital in Vitória, ES. METHODS: Fifty-four patients with tuberculoid and indeterminate leprosy were selected and treated with the single dose ROM Therapy approach. These patients were contacted from March 2006 up and until October 2006 for further clinical reevaluation. RESULTS: From the studies conducted, the following results were found to exist: 29 patients (85,2 percent; 95 percentCI: 70-100,4) were cured, 5 patients (14,7 percent; 95 percentCI: 7,4-22,0) relapsed, and 20 patients didn't return; however, there are no additional records of any notification of other treatment(s) in the State Department of Health's informational data banks. CONCLUSIONS: The study demonstrated a rate of cure of 90.8 percent and a rate of relapse of 9.2 percent after a period of seven to nine years using the single dose ROM Therapy approach. Additionally, this alternative treatment further demonstrated a better effectiveness for a single skin lesion smaller than four centimeters and with an appearance in less than five years.


Assuntos
Adolescente , Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Adulto Jovem , Hansenostáticos/administração & dosagem , Hanseníase/tratamento farmacológico , Minociclina/administração & dosagem , Ofloxacino/administração & dosagem , Rifampina/administração & dosagem , Método Duplo-Cego , Esquema de Medicação , Quimioterapia Combinada/métodos , Estudos Longitudinais , Hanseníase Tuberculoide/tratamento farmacológico , Hanseníase Tuberculoide/patologia , Hanseníase/patologia , Recidiva , Fatores de Tempo , Resultado do Tratamento
17.
Rev Soc Bras Med Trop ; 42(4): 420-4, 2009.
Artigo em Português | MEDLINE | ID: mdl-19802479

RESUMO

Leprosy relapse is the reappearance of the disease after regular treatment with current regimens and discharge due to cure. In this retrospective and descriptive cohort study, the aim was to evaluate the characteristics of cases of leprosy relapse in the State of Espírito Santo between 2000 and 2005. The investigation strategies consisted of monitoring the SINAN entries, with file analysis and case discussions at the State Reference Center. One hundred and four cases of relapse were studied, representing 1.12% of the new cases detected over this period. The greatest frequency was between 21 and 60 years of age; 59.6% were men; 44.2% presented relapse more than five years after discharge; 66.4% were multibacillary; and 42.2% presented positive bacilloscopy (complete bacilli) and therefore were relapse cases. Negatives bacilloscopy was observed in 57.8%. Prospective studies should be conducted to establish the real relapse rate.


Assuntos
Sistemas de Informação/estatística & dados numéricos , Hanseníase/diagnóstico , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Brasil , Métodos Epidemiológicos , Feminino , Humanos , Hanseníase/tratamento farmacológico , Hanseníase/microbiologia , Masculino , Pessoa de Meia-Idade , Recidiva , Fatores de Tempo , Adulto Jovem
18.
Rev. Soc. Bras. Med. Trop ; 42(4): 420-424, July-Aug. 2009. tab
Artigo em Português | LILACS | ID: lil-527184

RESUMO

Recidiva de hanseníase é o reaparecimento da doença, após tratamento regular com os esquemas vigentes e alta por cura. Neste estudo de coorte retrospectivo e descritivo o objetivo foi avaliar as características dos casos de recidiva de hanseníase no Estado do Espírito Santo entre 2000 e 2005. As estratégias de investigação foram: monitoramento das entradas no SINAN, análise das fichas e discussão dos casos no Centro de Referência Estadual. Foram estudados 104 casos de recidiva, representando 1,12 por cento em relação aos casos novos diagnosticados no período. A maior freqüência foi entre 21 a 60 anos; 59,6 por cento eram do sexo masculino; 44,2 por cento apresentaram a recidiva após cinco anos da alta; 66,4 por cento eram multibacilares, sendo 42,2 por cento com baciloscopias positivas (bacilos íntegros), portanto recidivas. Baciloscopias negativas foram observadas em 57,8 por cento. Estudos prospectivos devem ser feitos para estabelecimento da taxa real de recidiva.


Leprosy relapse is the reappearance of the disease after regular treatment with current regimens and discharge due to cure. In this retrospective and descriptive cohort study, the aim was to evaluate the characteristics of cases of leprosy relapse in the State of Espírito Santo between 2000 and 2005. The investigation strategies consisted of monitoring the SINAN entries, with file analysis and case discussions at the State Reference Center. One hundred and four cases of relapse were studied, representing 1.12 percent of the new cases detected over this period. The greatest frequency was between 21 and 60 years of age; 59.6 percent were men; 44.2 percent presented relapse more than five years after discharge; 66.4 percent were multibacillary; and 42.2 percent presented positive bacilloscopy (complete bacilli) and therefore were relapse cases. Negatives bacilloscopy was observed in 57.8 percent. Prospective studies should be conducted to establish the real relapse rate.


Assuntos
Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Adulto Jovem , Sistemas de Informação/estatística & dados numéricos , Hanseníase/diagnóstico , Brasil , Métodos Epidemiológicos , Hanseníase/tratamento farmacológico , Hanseníase/microbiologia , Recidiva , Fatores de Tempo , Adulto Jovem
19.
An. bras. dermatol ; 81(3): 291-293, jun. 2006. ilus
Artigo em Português | LILACS | ID: lil-432416

RESUMO

Descreve-se caso clínico de paciente tratado de hanseníase dimorfa, que utilizou automedicação, com doses variadas de corticosteróide oral, por longo período, devido à neuropatia hansênica. Desenvolveu lesão nódulo-cística, amarelada, com algumas crostas, envolta por halo eritêmato-acastanhado, na face interna da perna esquerda. O exame micológico direto confirmou a hipótese diagnóstica de feo-hifomicose.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA